- Home
- EW vs LVS Comparison
EW vs LVS Comparison
Compare EW & LVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EW
- LVS
- Stock Information
- Founded
- EW 1958
- LVS 1988
- Country
- EW United States
- LVS United States
- Employees
- EW N/A
- LVS N/A
- Industry
- EW Industrial Specialties
- LVS Hotels/Resorts
- Sector
- EW Health Care
- LVS Consumer Discretionary
- Exchange
- EW Nasdaq
- LVS Nasdaq
- Market Cap
- EW 45.5B
- LVS 37.8B
- IPO Year
- EW 2000
- LVS 2004
- Fundamental
- Price
- EW $74.55
- LVS $52.89
- Analyst Decision
- EW Buy
- LVS Buy
- Analyst Count
- EW 19
- LVS 13
- Target Price
- EW $85.74
- LVS $59.77
- AVG Volume (30 Days)
- EW 3.9M
- LVS 4.7M
- Earning Date
- EW 10-23-2025
- LVS 10-22-2025
- Dividend Yield
- EW N/A
- LVS 1.90%
- EPS Growth
- EW 188.09
- LVS N/A
- EPS
- EW 7.02
- LVS 1.97
- Revenue
- EW $5,685,100,000.00
- LVS $11,615,000,000.00
- Revenue This Year
- EW $13.25
- LVS $9.30
- Revenue Next Year
- EW $9.76
- LVS $4.87
- P/E Ratio
- EW $10.72
- LVS $26.70
- Revenue Growth
- EW 9.14
- LVS 1.62
- 52 Week Low
- EW $64.01
- LVS $30.18
- 52 Week High
- EW $83.00
- LVS $58.05
- Technical
- Relative Strength Index (RSI)
- EW 25.81
- LVS 45.06
- Support Level
- EW $80.08
- LVS $51.55
- Resistance Level
- EW $76.43
- LVS $58.05
- Average True Range (ATR)
- EW 1.65
- LVS 1.13
- MACD
- EW -0.79
- LVS -0.50
- Stochastic Oscillator
- EW 11.59
- LVS 20.31
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
About LVS Las Vegas Sands Corp.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore in 2031. Its Venetian and Palazzo Las Vegas assets in the US were sold to Apollo and Vici in 2022. After the sale of its Vegas assets, the company generates all its EBITDA from Asia, with its casino operations generating the majority of sales.